Refacto and activated partial thromboplastin time prolonged Patient Reports February 12, 2012

Refacto Side Effects Report #4590268-3
Refacto side effect was reported by a Consumer or non-health professional from on Feb 03, 2005. Male patient, 25 years of age, was diagnosed with prophylaxis and was treated with Refacto. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haemorrhage. Refacto dosage: unknown. Patient recovered.

Refacto Side Effects Report #5152697-9
Refacto side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Male patient, 47 years of age, weighting 176.4 lb, was diagnosed with factor viii deficiency and was treated with Refacto. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anti factor viii antibody positive, factor viii inhibition. Refacto dosage: unknown. During the same period patient was treated with ADVIL. Patient recovered.

Refacto Side Effects Report #4568985-0
Refacto side effect was reported by a Consumer or non-health professional from on Jan 13, 2005. Male patient, 47 years of age, weighting 176.4 lb, was diagnosed with factor viii deficiency and was treated with Refacto. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anti factor viii antibody positive, factor viii inhibition, haemorrhage. Refacto dosage: unknown. During the same period patient was treated with ADVIL. Patient recovered.

Refacto Side Effects Report #4690815-7
Refacto side effect was reported by a Consumer or non-health professional from on May 31, 2005. Female patient, 30 years of age, was diagnosed with factor viii deficiency and was treated with Refacto. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, breech presentation, coagulation factor viii level increased, deep vein thrombosis . Refacto dosage: unknown. Patient recovered.